hotspot -WSS

hotspot

author：knowledge 2025-10-01 22:57:17 - browse：6

Diversity in clinical trials concept — Adobe

The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

“An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
Next article： Biden tests positive for Covid

WSS

AstraZeneca stays mum on Medicare drug pricing negotiations

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

A public scorecard can help hold safety

AI gets buy

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Sanofi seeks simpler, safer CRISPR sickle cell cure

focus

hotspot

focus

United colonoscopy coverage change 'may cost lives,' doctors say

WHO calls for emergency meeting on new China virus, as cases spread

Heart attack and stroke risk calculators need revising

Medicare to cover more brain scans for Alzheimer’s patients

Trump demands the U.S. pay no more for drugs than other countries … again

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Sanofi seeks simpler, safer CRISPR sickle cell cure

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Global cancer cases to surge 77% by 2050, WHO report says

entertainment

Updated Covid vaccine has 54% effectiveness, new study suggests

Google and Epic fight stronger regulation of AI in health care

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Cosmetics set for new safety regulation. Why the industry is on board

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

A protest over insulin prices is seen as a fight for life

hotspot

explore

entertainment

Wikipedia